Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Zerit (stavudine) - Important Safety Information from Bristol-Myers Squibb Pharmaceuticals as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
21/03/2011
Problem Or Issue:
Important Safety Information communication from Bristol-Myers Squibb Pharmaceuticals on restriction of the indication for Zerit (stavudine) Hard Capsules and Powder for Oral Solution.
Important Safety Information - Zerit
« Back
Date Printed: 21/05/2024